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Enterobacter cloacae is an uncommon cause of meningitis. 
The organism is known to mutate to produce large 
amounts of cephalosporinase able to hydrolyze third- 
generation cephalosporins [l], which are often thought 
to be responsible for the selection of such resistant 
mutants. 
A newborn female, born at full term by vaginal 
delivery, was admitted to the neonatal intensive care 
unit with a lumbar meningomyelocele. Apgar scores 
were 10 and 10 at 1 and 5 min, respectively. Physical 
examination revealed an active neonate with only 
bladder dysfunction. No signs of neonatal infection 
were noted, and the serum C-reactive protein (CRP) 
level was less than 10 mg/L. 
Surgical closure of the meningomyelocele was 
performed 2 days later (day 3). Preoperative smears of 
the meningomyelocele were obtained for bacteriologic 
culture, and scanty Staphylococcus haemolyticus, Escherichia 
coli and Enterobacter cloacae were isolated. Postopera- 
tively, the patient became subfebrile. The peripheral 
white blood cell count was 10760/mm3, including 
63% polymorphonuclear leukocytes and 21% lympho- 
cytes, and serum CRP increased to 37 mg/L on day 4 
and then to 99 mg/L on day 5. The antibiotic suscepti- 
bilities of the Enterobacter cloacae is shown in Table 1. 
Therapy was initiated on day 5 with cefotaxime and 
vancomycin given intravenously (50 mg/kg 6-hourly 
and 10 mg/kg 12-hourly, respectively). 
Eight days after surgery, the patient had a rectal 
temperature between 38 and 39OC, and developed 
vomiting, a stiff neck and convulsions. She developed 
severe apnea and brachycardia which required mech- 
anical ventilation. Serum CRP levels remained in- 
creased at 196 mg/L on day 11, when we replaced 
vancomycin with fosfomycin (100 mg/kg 12-hourly). 
On day 12, cerebrospinal fluid cultures yielded Entero- 
bacter cloacae. Cerebrospinal fluid (CSF) contained 1094 
nucleated cells/mm3 (86% neutrophils, 14% monocytes). 
This isolate was susceptible in vitro to carbapenems, 
cefepime, ciprofloxacin, fosfomycin and aminoglyco- 
sides but was shown to produce high-level, derepressed 
cephalosporinase. In order to verify that the two 
Enterobacter cloacae isolates were clondy related, pulsed- 
field gel electrophoresis was performed on intact DNA 
preparations, as previously described for S. aureus [2], 
except that lysostaphin was not added (Figure 1). The 
results indicated that the two isolates were related. The 
second strain was therefore considered to be a resistant 
mutant of the previous strain. This prompted us to 
replace cefotaxime with imipenem (50 mg/kg three 
times daily). However, the infant developed ventricular 
dilatation, and on day 15 a ventricular external shunt 
was put in place. At this time, the CSF white cell count 
was 230/mm3, with 98% polymorphonuclear leuko- 
cytes, the protein content was 439 mg/mL and no 
glucose was found in the CSE Enterobacter cloacae was 
isolated from further CSF cultures. 
On day 17, because of poor CSF concentrations of 
imipenem (day 17, 1 mg/L; day 18, 0.1 mg/L) and 
according to previously published data [3], cefepime 
(37.5 mg/kg every 6 h) was substituted and on day 19 
amikacin (7.5 mg/kg every 12 h) was added. The in 
vitro bactericidal activity of this combination was 
Table 1 Antibiotic susceptibhty of the two strains isolated from cerebrospinal fluid before and after treatment with cefotaxime 
Methods Antibiotics Enterobacter cloacae 1 Enterobacter cloacae 2 
Amikacin 4/16 4/16 
MIC/MBC by macro Cefotaxime 1/4 32/256 
broth dilutions (mg/L) Cefepime 4/16 4/16 
Imipenem 2/32 4/32 
C o r r e s p o n d e n c e  4 4 5  
1 2 3 4 5 6 7  
400- 
300- 
200- 
100- 
50 - 
kb 
Figure 1 %a1 (lanes 1-3) and SpeI (lanes 5-7) PFGE 
analysis of an Enterobacter cloacae control isolate (lanes 1 and 
5) and of the sensitive (lanes 2 and 6) and resistant (lanes 3 
and 7) isolates from the patient. The %a1 pulsotypes 
(lanes 2 and 3) of both the sensitive and the resistant 
Enterobacter cloacae isolates appeared to be comparable, with 
10 DNA fragments distributed between 100 kb and 550 kb, 
and differed from that of another isolate (control) obtained 
in the same hospital in the same period. The SpeI pulso- 
types of the sensitive and the resistant isolates were similarly 
comparable (lanes 6 and 7), with nine DNA fragments 
distributed between 100 kb and 550 kb, but differed from 
that obtained with the control isolate (lanes 1 and 5). 
ascertained by means of time-kill curves. Amikacin plus 
cefepime resulted in a 51og decrease of the inoculum in 
less than 1 h. CSF concentrations of cefepime regularly 
ranged between 12 and 28 mg/L, those of fosfomycin 
were around 70 mg/L, and those of amikacin were 
around 3 mg/L. At the end of imipenem treatment, 
there was no CSF bactericidal activity, but it became 
significant after 2 days of cefepime, fosfomycin and 
amikacin treatment (from 1/8 to 1/16). Serum CRP 
level decreased from 294 mg/L (day 17) to 86 mg/L 
(day 22). and sterilization of CSF cultures was obtained 
after 3 days of therapy. Unfortunately, multiple subdural 
empyemas developed on the next day, together with 
marked ventricular dilatation and cerebral atrophy, 
probably due to the unfavorable response to the 
previous therapy. 
The usual treatment of a CSF infection due to a 
Gram-negative organism is a third-generation cephalo- 
sporin used alone. Thus, we chose cefotaxime but, as 
described in the literature, including four cases of 
enterobacter meningitis [4,5], the E~zterobacfer cloacae 
developed resistance by overproduction of a derepressed 
type 1 p-lactamase after mutation [6,7]. Cefepime 
is highly resistant to hydrolysis by this periplasmic p- 
lactamase, in part because of the low affinity of this 
enzyme for the drug [8,9] and in part because of the 
extremely rapid penetration of this drug into the 
periplasmic space. 
The efficacy of cefepime in the treatment of 
bacterial meningitis has been previously demonstrated 
in experimental animals models [10,11] and in infants 
with non-enterobacter meningitis [3]. 
In our case, cefepime in combination proved for 
the first time its usefulness in readily penetrating the 
CSF, achieving high local concentrations and thus 
sterilizing the CSF by ensuring local bactericidal 
activity. The use of cefepime as first-line therapy might 
have prevented the selection of a resistant mutant. 
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Mollaret meningitis with orolabial herpes and 
large lysed ghost cells 
Clin Microbiol Infect 1999; 5: 446-448 
Mollaret’s meningitis is a benign aseptic meningitis of 
unclear etiology characterized by headache, meningism, 
malaise, and fever, which recurs at intervals ranging 
from weeks to months [l]. Signs and symptoms of 
meningeal irritation appear acutely, in association with 
fever and pleocytosis of mononuclear cells. These 
episodes last for 2-5 days, or occasionally longer, and 
remit spontaneously. Five to 15 attacks may occur, 
separated by symptom-free intervals ofweeks to months. 
Transient neurologic abnormalities may be present 
during the attacks, but they disappear after the acute 
illness. The diagnosis of Mollaret’s meningitis is made 
only after other recognized causes of recurrent lympho- 
cytic meningitis have been excluded. 
A 7-year-old girl with Mollaret’s meningitis, a 
rarely reported disease in childhood, presented with the 
major clinical aspects, laboratory findings and the ghost 
cells in cerebrospinal fluid (CSF), which are known as 
hallmarks of Mollaret’s meningitis (Figure 1). The child 
presented with a 5-day history of fever, headache, 
nausea, vomiting and meningism. Previously, she had 
had three similar episodes. She had no history of head 
injury or recent dental work. She had ruptured herpetic 
vesicles on her mouth and lips, a stiff neck, and positive 
Kernig’s and Brudzinski’s signs. 
The first CSF examination in August 1997 revealed 
a normal opening pressure, 180 white blood cells/mm3 
(95% polymorphonuclear cells), protein 175 mg/dL, 
glucose 21 mg/dL, chloride 129 mmol/L, 1gG 37.4 
mg/dL, IgM 5.78 mg/dL, and IgE 13 IU/mL, serum 
IgG level 1230 mg/dL, IgM 120 mg/dL, IgE 456 
IU/mL, and IgG index 0.54, blood urea nitrogen 
39 mg/dL, glucose 97 mg/dL, total protein 6.3 g/dL, 
alanine aminotransferase 20 IU/L, aspartate aminotrans- 
ferase 18 IU/L, Na+ 124 mmol/L and K+ 6 mmol/L. 
After 4 days, lumbar punctures revealed only 40 leuko- 
cytes (most of them were mononuclear cells) and many 
special types of large cell that have been called ‘endo- 
thelial’, per cubic millimeter. After 36 h, the last lumbar 
punctures revealed only 30 leukocytes and no ghost 
cells per cubic millimeter. Other laboratory tests 
showed the following: hemoglobin 11 g/dL, hematocrit 
40%, leukocytes 40 OOO/mm3,  platelets 157 OOO/mm3. 
Peripheral blood smear showed 93% neutrophils, 7% 
lymphocytes, polychromosia, and erythrocyte sedimen- 
tation rate 105 mm/h. Urinalysis showed no specific 
findings. CRP (+ + +), AS0 50 Todd Units, Latex RF 
Figure 1 Mollaret’s large mononuclear cells in the CSF of 
our patient (HE X 40). 
